Approval in adults and children aged 6 years and older supported by Phase 3 trial demonstrating Dupixent significantly reduced nasal signs and symptoms, and systemic corticosteroid use or surgery compared to placebo AFRS is a chronic type 2 inflammatory disease of the sinuses characterized by an allergic hypersensitivity to fungi, often requiring surgery with high rates of post-operative recurrence Dupixent is now approved in the U.S. to treat nine distinct diseases driven in part by type 2 inflammation, i ...

U.S. spot ETF expands regulated access to the Sui ecosystem as institutional momentum acceleratesNEW YORK, Feb. 24, 2026 (GLOBE NEWSWIRE) -- 21shares, one of the world’s leading issuers of crypto exchange-traded funds (ETFs), today announced the launch of the 21shares Spot SUI ETF (TSUI), which has officially started trading on Nasdaq. TSUI allows U.S. investors to integrate SUI into their portfolios via traditional brokerage accounts, without the need to directly hold or manage digital wallets. TSUI is not ...

Core Viewpoint - WisdomTree Multi Asset Issuer Public Limited Company has successfully passed an Extraordinary Resolution to reduce the principal amount of the WisdomTree S&P 500 VIX Short-Term Futures 2.25x Daily Leveraged Securities from USD 0.481 to USD 0.0481, indicating a significant adjustment in the value of the affected securities [2]. Group 1 - The Extraordinary Resolution was passed at an adjourned meeting held on 24 February 2026 [2]. - The reduction in principal amount reflects a change in the financial structure of the affected securities [2]. - A Deed of Amendment has been executed to implement the proposed amendments to the Trust Deed effective from 24 February 2026 [3].

Core Viewpoint - Clean Energy Technologies, Inc. (CETY) is updating its investment in a convertible bond issued by China Ruifeng Renewable Energy Holdings Limited, which is planning a significant investment in an artificial intelligence computing center project in China [1][2][3]. Investment Update - CETY has entered into a purchase agreement to acquire a portion of a convertible bond from China Ruifeng [2]. - China Ruifeng announced plans for a potential investment of approximately US$ 3.4 billion through its subsidiary Leading Win Resources Limited to develop a large-scale artificial intelligence computing center in Xuanhua District, Hebei Province, China [3]. Project Details - The project aims to develop an artificial intelligence computing center integrated with renewable power supply and energy storage infrastructure, targeting high-density computing workloads [4]. - Initial operations for the project are expected to launch in 2028, and it may include a grid-side energy storage facility utilizing lithium iron phosphate technology [4]. Company Positioning - CETY is not a party to the investment framework agreement and has not entered into any definitive agreements with China Ruifeng regarding the project [5]. - The company notes that such projects typically require advanced energy infrastructure solutions, aligning with CETY's technology focus and strategic objectives [5]. - CETY's experience in energy infrastructure development positions it to evaluate potential collaborations with Leading Win Resources Limited or its affiliates [5].

VANCOUVER, British Columbia, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Forte Minerals Corp. (“Forte” or the “Company”) (CSE: CUAU) (OTCQB: FOMNF) (Frankfurt: 2OA) a Canadian copper and gold exploration company focused on Peru, is pleased to announce that it will exhibit at the Prospectors & Developers Association of Canada (“PDAC”) Convention 2026, taking place March 1–4, 2026 at the Metro Toronto Convention Centre in Toronto. Visit Forte Minerals Corp at Booth 2736 in the Investors Exchange (South Building). PDAC ...

VANCOUVER, British Columbia, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Forte Minerals Corp. (“Forte” or the “Company”) (CSE: CUAU) (OTCQB: FOMNF) (Frankfurt: 2OA) a Canadian copper and gold exploration company focused on Peru, is pleased to announce that it will exhibit at the Prospectors & Developers Association of Canada (“PDAC”) Convention 2026, taking place March 1–4, 2026 at the Metro Toronto Convention Centre in Toronto. Visit Forte Minerals Corp at Booth 2736 in the Investors Exchange (South Building). PDAC ...

BROSSARD, Quebec, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a company dedicated to the early detection of critical eye-related health issues using advanced technology based on Artificial Intelligence (AI), is pleased to announce that it will be presenting at the Centurion One Capital 9th Annual Conference in Toronto, Canada March 5th 2026. This exclusive gathering unites the most significant group of Canadian investors in sea ...

HOUSTON, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Freight Technologies, Inc. (Nasdaq: FRGT, “Fr8Tech” or the “Company”), a technology-centric logistics company offering a diversified portfolio of AI software solutions designed to address key inefficiencies in the supply chain, today announced strong productivity gains across key operating metrics for customers and its internal operations. The Company's intelligence-led and automation-driven solutions are improving the pace, accuracy, and scale of customers’ freigh ...

Core Insights - Edesa Biotech, Inc. announced positive results from a Phase 3 study of paridiprubart, demonstrating a significant reduction in 28-day mortality across a broad patient population [1][2][3] Study Results - The study involved 278 patients, including 104 requiring invasive mechanical ventilation (IMV) and 174 non-IMV patients, showing a 27% relative reduction in mortality from 33% to 24% (p<0.001) [2][3] - In a subgroup of 174 non-IMV patients, paridiprubart reduced mortality from 23% to 15%, a 35% relative reduction (p<0.05) [4] - Exploratory analyses indicated consistent mortality reductions in patients with serious comorbidities, with overall adverse events being low and similar between treatment groups [5] Patent and Regulatory Developments - Edesa has filed provisional patent applications for paridiprubart's use in treating sepsis, acute kidney injury, and pneumonia, with core patents extending into the 2030s [6] - The company is advancing regulatory discussions and exploring strategic collaborations to accelerate development and broaden access [8] Future Studies and Presentations - Paridiprubart is being evaluated in a separate U.S. government-funded study with enrollment ongoing for approximately 200 subjects [9] - Edesa has been selected for an oral presentation at the ATS 2026 conference to share additional findings from the Phase 3 study [12] Mechanism and Background - Paridiprubart is a first-in-class anti-TLR4 antibody designed to modulate the immune response in various critical conditions, including ARDS, which has high mortality rates and limited treatment options [19][20] - ARDS accounts for 10% of ICU admissions globally, representing over 3 million patients annually [20] Company Overview - Edesa Biotech focuses on developing innovative treatments for inflammatory and immune-related diseases, with a clinical pipeline that includes both medical dermatology and respiratory therapeutic areas [21]

Core Insights - SemiCab has been awarded a pilot program with Hindustan Coca-Cola Beverages Private Limited to launch a transportation program on its collaborative freight platform, aiming to cut transportation costs and reduce empty miles for Coca-Cola India [1][2] Company Overview - Algorhythm Holdings, Inc. is a leading AI technology company focused on the growth of SemiCab, which addresses supply-chain problems globally through its AI-enabled, cloud-based Collaborative Transportation Platform [6] - SemiCab's platform utilizes artificial intelligence and machine learning to optimize freight logistics, enabling fully loaded round trips and dynamic route optimization, which leads to improved asset utilization and reduced empty backhaul miles [4][6] Industry Impact - The partnership with Coca-Cola India marks a significant milestone in SemiCab's expansion within India's fast-moving consumer goods (FMCG) sector, following recent contract wins with other industry leaders such as Procter & Gamble India and Unilever India [2][5] - The pilot program is designed to evaluate SemiCab's effectiveness in reducing empty miles and improving delivery efficiency, which could lead to a broader rollout of its solutions if successful [3][5]